2 completed, 1 active not recruiting, 1 recruiting, 1 terminated. 6 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 2, Active not recruiting 1, Recruiting 1, Terminated 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
Follow Oligoastrocytoma: new trials by email Literature Review of Oligoastrocytoma trials Research Report on Oligoastrocytoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas Quality-of-Life Assessment, Questionnaire Administration, Radiation Therapy - Anaplastic Astrocytoma, IDH-Wildtype, Anaplastic Oligoastrocytoma | Phase 2 | Recruiting | M.D. Anderson Cancer Center | 40 | 2020-01-30 | 2026-07-16 |
| Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma Biospecimen Collection, Intensity-Modulated Radiation Therapy, Laboratory Biomarker Analysis - Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma | Phase 2 | Active not recruiting | NRG Oncology | 120 | 2018-01-23 | 2026-07-28 |
| Safety and Efficacy of PD0332991 (Palbociclib), a Cyclin-dependent Kinase 4 and 6 Inhibitor, in Patients With Oligodendroglioma or Recurrent Oligoastrocytoma Anaplastic With the Activity of the Protein RB Preserved Palbociclib - Oligodendroglioma, Oligoastrocytoma | Phase 2 | Completed | Grupo Español de Investigación en Neurooncología | 34 | 2015-10-25 | 2024-11-22 |
| A Prospective Cohort to Study the Effect of Temozolomide on IDH Mutational Low Grade Gliomas Temozolomide - Astrocytoma, Oligodendroglioma | Phase 2 | Unknown | Huashan Hospital | 54 | 2014-06-01 | 2019-02-21 |
| A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma Temozolomide and O6-Benzylguanine - Glioma, Astrocytoma | Phase 2 | Terminated | Keryx / AOI Pharmaceuticals, Inc. | 32 | 2006-10-01 | 2012-02-09 |
| Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain Tumors Carboplatin, Etoposide, Etoposide Phosphate - Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma | Phase 1 / Phase 2 | Completed | OHSU Knight Cancer Institute | 33 | 2005-09-15 | 2022-03-17 |
Astrocytoma (6) · Oligodendroglioma (6) · Glioma (3) · Glioblastoma (1)
Neoplasms (6) · Neoplasms by Histologic Type (6) · Neoplasms, Germ Cell and Embryonal (6) · Neoplasms, Glandular and Epithelial (6) · Neoplasms, Nerve Tissue (6) · Neoplasms, Neuroepithelial (6) · Neuroectodermal Tumors (6) · Glioma (3)
Temozolomide (4) · Carboplatin (1) · Etoposide (1) · Magnetic Resonance Spectroscopy (1) · Mannitol (1) · Melphalan (1) · O(6)-benzylguanine (1) · Proton Therapy (1) · Protons (1) · Radiation (1) · Radiotherapy (1) · Radiotherapy, Intensity-Modulated (1) · Specimen Handling (1) · etoposide phosphate (1) · palbociclib (1)
Grupo Español de Investigación en Neurooncología (1) · Huashan Hospital (1) · Keryx / AOI Pharmaceuticals, Inc. (1) · M.D. Anderson Cancer Center (1) · NRG Oncology (1) · OHSU Knight Cancer Institute (1)
United States (4) · China (1) · Spain (1)
David R Grosshans (1) · Debra N Yeboa (1) · Edward A Neuwelt (1) · Jennifer Quinn, MD (1) · Jinsong Wu, Professor (1)
U10CA180868 (1)